Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¾ÏÈ­Çп¹¹æÀ̶õ ¹«¾ùÀ̸ç ÀÓ»ó½ÃÇèÀ» ´ÜÃàÇϱâ À§ÇÏ¿© ¿£µåÆ÷ÀÎÆ® ¹ÙÀÌ¿À¸¶Ä¿¸¦ ¾î¶»°Ô ´ëÄ¡ÇÏ¿© Çϳª What is Chemoprevention and How can Surrogate Endpoint Biomarkers Shorten Clinical Trials

´ëÇѾϿ¹¹æÇÐȸÁö 1996³â 1±Ç 1È£ p.39 ~ 45
Boone Charles W.,
¼Ò¼Ó »ó¼¼Á¤º¸
 ( Boone Charles W. ) 
USA National Institute of Health National Cancer Institute

Abstract

[ÃʷϾøÀ½:No abstract]

Å°¿öµå

Chemoprevention;Endopoint biomarckers;Clinical trials

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸